ENDODIATHERMY PLUS PHOTOCOAGULATION AS TREATMENT OF SCLEROTOMY SITE VASCULARIZATION SECONDARY TO PARS PLANA VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY
Authors:
- 1 July 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Retina
- Vol. 32 (7) , 1310-1315
Abstract
Purpose: To evaluate the results of surgery with pars plana vitrectomy (PPV), endodiathermy of sclerotomy site fibrovascularization and adjuvant photocoagulation of the peripheral retina to the pars plana as treatment of recurrent vitreous hemorrhage secondary to PPV for proliferative diabetic retinopathy (PDR). Methods: Tertiary care center, Barraquer Center of Ophthalmology, Barcelona, Spain. Prospective interventional study of 14 eyes of 14 consecutive patients aged 20 years to 47 years with recurrent vitreous hemorrhage because of sclerotomy site neovascularization secondary to PPV for PDR. All patients were treated by cataract, or transparent lens, extraction with intraocular lens implantation plus 20-gauge PPV of the vitreous base, including incarcerated vitreous of the sclerotomy site, together with endodiathermy of sclerotomy site fibrovascular tissue and adjuvant photocoagulation to the pars plana. Preoperative evaluation was performed by 20-MHz, high-resolution, anterior-segment ultrasonography of the neovascularized sclerotomy sites, pre- and postoperative visual acuity (logarithm of the minimum angle of resolution), and postoperative rebleeding rates. Results: Recurrent vitreous hemorrhage appeared 8 ± 4 months after the initial PPV for PDR. Ten (71%) patients had isolated vascularization of a single sclerotomy site and 4 (29%) had vascularization of 2 sclerotomy sites. Nine of the 18 vascularized sites (50%) corresponded to optical fiber sclerotomies, 7 (39%) to vitreotome, and 2 (11%) to infusion sclerotomies. All the neovascularized sclerotomies presented sentinel vessels in the anterior segment. No patient showed postoperative recurrent vitreous hemorrhage during follow-up of 23 ± 10 months; all showed improved visual acuity, from initial 2.23 (±1.13 standard deviation) to final 0.23 (±0.09 standard deviation). Conclusion: According to our study, the technique of choice for the treatment of recurrent vitreous hemorrhage secondary to PPV for PDR is endodiathermy of sclerotomy site fibrovascularization and adjuvant photocoagulation of the peripheral retina to the pars plana. This technique treats the etiology of the problem, improves final best-corrected visual acuity, and, most importantly, helps prevent recurrent bleeding.Keywords
This publication has 34 references indexed in Scilit:
- VITREOUS HEMORRHAGE AFTER THE 25-GAUGE TRANSCONJUNCTIVAL SUTURELESS VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHYRetina, 2010
- Entry site treatment to prevent late recurrent postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathyBritish Journal of Ophthalmology, 2009
- Intravitreal bevacizumab in recurrent diabetic vitreous haemorrhage after vitrectomyActa Ophthalmologica, 2008
- Intravitreal Triamcinolone Acetonide in Eyes With Recurrent Postvitrectomy Diabetic Vitreous HemorrhageAmerican Journal of Ophthalmology, 2006
- Cryotherapy of the Anterior Retina and Sclerotomy Sites in Diabetic Vitrectomy to Prevent Recurrent Vitreous HemorrhageOphthalmology, 2005
- Risk Factors for Postoperative Hemorrhage after Vitrectomy for Diabetic RetinopathyOphthalmic Epidemiology, 2005
- Silicone oil concentrates fibrogenic growth factors in the retro-oil fluidBritish Journal of Ophthalmology, 2004
- Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage*1Ultrasound biomicroscopy findingsOphthalmology, 2004
- Die Kryokoagulation in der Therapie der proliferativen diabetischen RetinopathieKlinische Monatsblätter für Augenheilkunde, 1997
- Die Rolle des Glaskörpers in der diabetischen RetinopathieKlinische Monatsblätter für Augenheilkunde, 1993